| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $745.6M | — | +9.9% |
| Cost of Revenue | $470.5M | — | +11.2% |
| Gross Profit | $275.1M | — | +7.8% |
| R&D Expense | $12.5M | — | +23.8% |
| SG&A Expense | $174.5M | — | +23.9% |
| Operating Income | $90.5M | — | -17.6% |
| Pre-tax Income | $64.9M | — | -30.3% |
| Income Tax | $13.1M | — | -36.0% |
| Net Income | $47.6M | — | -29.3% |
| EPS (Basic) | $0.78 | — | -29.1% |
| EPS (Diluted) | $0.78 | — | -29.1% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.00B | +440.6% | +244.9% |
| Accounts Receivable | $488.5M | +8.2% | +17.8% |
| Inventory | $520.6M | +8.1% | +15.5% |
| Current Assets | $2.17B | +72.0% | +68.7% |
| Total Assets | $5.62B | +18.0% | +33.4% |
| Current Liabilities | $730.0M |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $46.9M | — | +32.5% |
| Capital Expenditures | $13.7M | — | +87.9% |
| Investing Cash Flow | -$13.4M | — | -399.4% |
| Financing Cash Flow | $786.2M | — | +6092.7% |
| Free Cash Flow | $33.2M | — | +18.1% |
| +8.6% |
| Long-term Debt | $2.03B | +64.9% | +92.4% |
| Total Liabilities | $3.39B | +32.7% | +49.5% |
| Stockholders' Equity | $2.19B | +1.1% | +14.7% |